Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients

Author： Milla Paola   Fiorito Chiara   Soria Francesco   Arpicco Silvia   Cattel Luigi   Gontero Paolo  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.73, Iss.3, 2014-03, pp. : 503-509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Randomized Intergroup Comparison of Bacillus Calmette-Guerin Immunotherapy and Mitomycin C Chemotherapy Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder - A Southwest Oncology Group Study

By Lamm D.L.   Blumenstein B.A.   Crawford E.D.   Crissman J.D.   Lowe B.A.   Smith J.A.   Sarosdy M.F.   Schellhammer P.F.   Sagalowsky A.I.   Messing E.M.   Loehrer P.   Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 3, 1995-05 ,pp. : 119-126

Elsevier

Access to resources Recommend Favorite

Adjuvant Intravesical Mitoxantrone After Transurethral Resection of Primary Superficial Transitional Cell Carcinoma of the Bladder. A Prospective Randomised Study

By Flamm J.   Donner G.   Oberleitner S.   Hausmann R.   Havelec L.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 143-146

Elsevier

Access to resources Recommend Favorite

What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder? - Phase III study of intravesical instillation of epirubicin, BCG tice and BCG tice plus isoniazid in intermediate and high risk TaT1 papillary carcinoma of the bladder

By Schellhammer P.F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 3, 1998-05 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder

By Morgan B.E.   Salup R.   Morgan M.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

By Lee Jeeyun   Im Young-Hyuck   Cho Eun   Hong Yong   Lee Hyo   Kim Hyo   Kim Mi-Jin   Kim Kwhanmien   Kang Won   Park Keunchil   Shim Young  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite